Lb Pharmaceuticals Inc (LBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 12-2024 | 09-2024 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 269,744 | N/A | 0 |
| Marketable Securities | N/A | 44,735 | N/A | 0 |
| TOTAL | $N/A | $316,401 | $N/A | $0 |
| Non-Current Assets | ||||
| PPE Net | N/A | 1,635 | N/A | N/A |
| Other Non-Current Assets | 0 | 2,710 | 0 | 0 |
| TOTAL | $N/A | $4,345 | $N/A | $N/A |
| Total Assets | $N/A | $320,746 | $N/A | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 2,590 | 0 | 0 |
| Accrued Expenses | N/A | 3,327 | N/A | 0 |
| TOTAL | $N/A | $6,647 | $N/A | $0 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 3,878 | 0 | 0 |
| TOTAL | $N/A | $3,878 | $N/A | $N/A |
| Total Liabilities | $N/A | $10,525 | $N/A | $0 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 28,675 | 25,299 | N/A | N/A |
| Common Shares | N/A | 3 | N/A | 0 |
| Retained earnings | N/A | -118,056 | N/A | 0 |
| Other shareholders' equity | 0 | -53 | 0 | 0 |
| TOTAL | $N/A | $310,221 | $N/A | $0 |
| Total Liabilities And Equity | $0 | $320,746 | $0 | $0 |